These ROS play a role in cell signaling and can influence tumor progression and resistance to therapies, particularly in cancers like non-small-cell lung cancer (NSCLC), where they are linked to EGFR-TKI resistance [13]. This evidence concerns the gene EGFR and neoplasm.